{"id":"W3134169755","doi":"10.1016/j.esmoop.2021.100063","title":"Tucatinib approval by EMA expands options for HER2-positive locally advanced or metastatic breast cancer","year":2021,"lang":"en","type":"editorial","venue":"ESMO Open","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Metastatic breast cancer; Oncology; Medicine; Breast cancer; Cancer; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001804246,0.0003109278,0.0005310319,0.001082311,0.0005220673,0.002019492,0.0004610717,0.001689398,0.04550667],"category_scores_gemma":[0.002710289,0.000152291,0.0009302013,0.0009231507,0.0003476277,0.001398398,0.000853062,0.002893455,0.01180763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008677688,"about_ca_system_score_gemma":0.001248902,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001357661,"about_ca_topic_score_gemma":0.005701232,"domain_scores_codex":[0.9992414,0.0002165088,0.00005570384,0.0000624233,0.0002735064,0.0001504359],"domain_scores_gemma":[0.9992973,0.0001835288,0.0001137462,0.00003854688,0.0001874004,0.0001795453],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001723131,0.0001731276,0.0006373015,0.001236995,0.00005949037,0.0003690582,0.00007267353,0.0002037447,0.003858713,0.005280471,0.57845,0.4079352],"study_design_scores_gemma":[0.0007388438,0.0003730796,0.002885165,0.0006514763,0.00005578019,0.0004769226,0.00003008254,0.0001993249,0.001014208,0.001366419,0.9921976,0.00001112003],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"editorial","genre_scores_codex":[0.03904261,0.2634798,0.003424915,0.1568395,0.01570972,0.0007132103,0.01784783,0.00235285,0.5005895],"genre_scores_gemma":[0.3041613,0.2451304,0.00496298,0.1459987,0.0145672,0.0007801789,0.03386574,0.000904965,0.2496285],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.04550667,"threshold_uncertainty_score":0.152235,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02494866263595423,"score_gpt":0.3808935649606516,"score_spread":0.3559449023246973,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}